Home › Alzheimer's Disease › NCT07812337
Evaluation of a Decision-Support Tool for Blood Biomarker Testing for Alzheimer's Disease in Primary Care
Pilot Evaluation of a Tool to Support Communication About Blood Biomarker Testing for Cognitive Complaints in Primary Care
Who can join
Ages 50 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Simulation 1 and Simulation 2: PCPs with experience and interest in cognitive diagnosis. * Simulation 2: community dwelling older adults age 50 or older are eligible. Exclusion Criteria (PCP): none Participant Exclusion Criteria: * Not fluent in English * age \<50 years * pre-existing diagnosis of cognitive impairment * having an activated medical decision-make r or not living independently in the community. There will be no exclusion based upon sex/gender, race, or ethnicity.
About the study
The goal of the current study is to evaluate a decision-support tool intended to help primary care providers (PCPs) communicate with patients about blood biomarker testing for Alzheimer's Disease, enhancing shared-decision making and information sharing in the clinical space. The main questions it aims to answer are:
* Is the decision-support tool accepted and easy to use for PCPs? * Does using the tool improve shared decision-making during clinical encounters? Researchers will compare clinical encounters between PCPs who do not use the tool to discuss blood biomarker testing for Alzheimer's Disease, versus PCPs who have been trained to utilize the tool during clinical encounters to see whether the tool effectively facilitates shared-decision making.
What is being tested
- Shared decision-making support tool (other)
Sponsor: University of Wisconsin, Madison · Participants: 70 · Started: Oct 1, 2026
Contact the study team
- Fred Ketchum, M.D., Ph.D. · Phone: 608-265-5523
Official record on ClinicalTrials.gov — NCT07812337
Locations in the U.S.
| Wisconsin | School of Medicine and Public Health, University of Wisconsin, Madison |
Conditions
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.